Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Library Health Topics Collection Guidelines American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients with Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Document Actions

American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients with Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy

Publication Details
Author(s):
  • ASCO (US) - American Society of Clinical Oncology
Country(ies) of application:
  • United States
Language(s):
  • English
Type of Publication:
Guideline
Primary Contact:
Kate Einhaus
kaitlin.einhaus@asco.org
Publication URL:
Open Publication URL in a new window
Publication Scope:
  • Management
Publication Status:
Published
Date of publication:
Apr 20, 2009
Due for Review:
-
Diseases / Conditions Addressed
MeSH Terms addressed:
  • Cancer / Neoplasms (C04)
    • Gastrointestinal Neoplasms (C04.588.274.476)
      • Colorectal Neoplasms (C04.588.274.476.411.307)
  • Digestive System Disorders / Diseases (C06)
    • Gastrointestinal Diseases (C06.405)
      • Intestinal Diseases (C06.405.469)
  • Diagnosis (E01)
    • Diagnostic Techniques and Procedures (E01.370)
  • Therapeutics (E02)
    • Biological Therapy (E02.095)
      • Gene Therapy (E02.095.301)
  • Medical Genetics (G01.273.343.315)
Guideline key questions
Page last updated: May 11, 2012

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.